ResTORbio announces additional positive mid-stage data on RTB101; shares up 4% [Seeking Alpha]
RESTORBIO (TORC)
Last restorbio earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.restorbio.com/investor-resources/investor-faqi
Company Research
Source: Seeking Alpha
ResTORbio announces additional positive mid-stage data on RTB101; shares up 4%Additional results from a Phase 2b clinical trial evaluating resTORbio's (TORC+3.7%) TORC1 inhibitor RTB101 in patients with respiratory tract infections (RTI) continued to show its effectiveness.Patients receiving 10 mg of RTB101 once daily for 16 weeks experienced a 52.1% reduction in severe RTI symptoms compared to placebo (p=0.034). Patients receiving 5 mg each day over the same time period experienced a 41.3% reduction versus control although the separation was not statistically significant.No reduction in the proportion of patients with severe RTI symptoms was observed in those receiving twice-daily 10 mg doses of RTB101 or RTB101 combined with Novartis' AFINITOR (everolimus).Detailed results will be submitted for presentation at future medical conferences.Phase 3 development should commence n H1 2019.Previously:ResTORbio's RTB101 successful in mid-stage study; shares up 144% premarket (July 25)See all
Show less
Read more
Impact Snapshot
Event Time:
TORC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TORC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TORC alerts
High impacting RESTORBIO news events
Weekly update
A roundup of the hottest topics